Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panagiotis Alexopoulos

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
Journal of Alzheimer'S Disease : JAD|April 24, 2013
Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signaturePanagiotis Alexopoulos, Liang-Hao Guo, Meizi Jiang, et al.
Neuropsychiatric Disease and Treatment|January 1, 2016
Cerebrospinal fluid biomarkers for Alzheimer's disease: the role of apolipoprotein E genotype, age, and sexShima Mehrabian, Panagiotis Alexopoulos, Marion Ortner, et al.
Human Genome Variation|April 16, 2016
Excess of rare coding variants in PLD3 in late- but not early-onset Alzheimer's diseaseEva C Schulte, Alexander Kurz, Panagiotis Alexopoulos, et al.
Applied Neuropsychology. Adult|July 21, 2025
Finger tapping and paratonia assessment in older adults with and without Mild cognitive impairment, motor-cognitive correlationsTriantafyllia Kalantzakou, Vasileios Mantas, Eleni Boutsika, et al.
Frontiers in Neuroscience|May 6, 2016
Diagnostic Potential of Pulsed Arterial Spin Labeling in Alzheimer's DiseaseStefano Trebeschi, Isabelle Riederer, Christine Preibisch, et al.
Translational Neurodegeneration|August 31, 2019
Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PETOliver Goldhardt, Inanna Warnhoff, Igor Yakushev, et al.
Rheumatology International|June 13, 2026
Stress exposure prior to diagnosis and clinical characteristics in systemic lupus erythematosus: a cross-sectional studyEleni Papachristodoulou, Loukas Kakoullis, Costas A Christophi, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 26, 2011
Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer's disease measured by pulsed arterial spin labeling MRIPanagiotis Alexopoulos, Christian Sorg, Annette Förschler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 21, 2015
Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive ImpairmentTimo Grimmer, Carolin Wutz, Panagiotis Alexopoulos, et al.
Journal of Alzheimer'S Disease : JAD|May 25, 2011
Hippocampal volume differences between healthy young apolipoprotein E ε2 and ε4 carriersPanagiotis Alexopoulos, Tanja Richter-Schmidinger, Marco Horn, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Journal of Alzheimer'S Disease : JAD|April 24, 2013
Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signaturePanagiotis Alexopoulos, Liang-Hao Guo, Meizi Jiang, et al.
Neuropsychiatric Disease and Treatment|January 1, 2016
Cerebrospinal fluid biomarkers for Alzheimer's disease: the role of apolipoprotein E genotype, age, and sexShima Mehrabian, Panagiotis Alexopoulos, Marion Ortner, et al.
Human Genome Variation|April 16, 2016
Excess of rare coding variants in PLD3 in late- but not early-onset Alzheimer's diseaseEva C Schulte, Alexander Kurz, Panagiotis Alexopoulos, et al.
Applied Neuropsychology. Adult|July 21, 2025
Finger tapping and paratonia assessment in older adults with and without Mild cognitive impairment, motor-cognitive correlationsTriantafyllia Kalantzakou, Vasileios Mantas, Eleni Boutsika, et al.
Frontiers in Neuroscience|May 6, 2016
Diagnostic Potential of Pulsed Arterial Spin Labeling in Alzheimer's DiseaseStefano Trebeschi, Isabelle Riederer, Christine Preibisch, et al.
Translational Neurodegeneration|August 31, 2019
Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PETOliver Goldhardt, Inanna Warnhoff, Igor Yakushev, et al.
Rheumatology International|June 13, 2026
Stress exposure prior to diagnosis and clinical characteristics in systemic lupus erythematosus: a cross-sectional studyEleni Papachristodoulou, Loukas Kakoullis, Costas A Christophi, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 26, 2011
Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer's disease measured by pulsed arterial spin labeling MRIPanagiotis Alexopoulos, Christian Sorg, Annette Förschler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 21, 2015
Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive ImpairmentTimo Grimmer, Carolin Wutz, Panagiotis Alexopoulos, et al.
Journal of Alzheimer'S Disease : JAD|May 25, 2011
Hippocampal volume differences between healthy young apolipoprotein E ε2 and ε4 carriersPanagiotis Alexopoulos, Tanja Richter-Schmidinger, Marco Horn, et al.
Pageof 11